Text Size
930 studies found for:    Vaginal Diseases: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Vaginal Diseases: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 30 mg;   Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Nonhormonal vaginal lubricant
2 Completed A Clinical Study to Evaluate the Safety of Ospemifene
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo
3 Completed A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Placebo;   Drug: Ospemifene 5 mg;   Drug: Ospemifene 15 mg;   Drug: Ospemifene 30 mg
4 Completed Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Non-hormonal vaginal lubricant
5 Completed Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Conditions: Atrophy;   Vaginal Diseases
Intervention: Drug: Ospemifene
6 Completed Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene (Dose 1);   Drug: Ospemifene (Dose 2);   Drug: Placebo
7 Completed Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
Conditions: Vaginosis, Bacterial;   Vaginal Infection
Interventions: Drug: GW05;   Drug: Metronidazole
8 Unknown † Hyaluronic Acid and Vaginal Distress
Condition: Vaginal Disease
Intervention: Other: hyaluronic acid pill
9 Recruiting Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females
Conditions: Ureteral Stent Occlusion;   Exposure Laser;   Ureterostomy; Functional Disturbance;   Vaginal Diseases;   Injury of Bladder;   Excessive Repair;   Calculi
Intervention:
10 Completed Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn`s Disease (ALOREVA)
Conditions: Rectovaginal Fistula;   Crohn Disease
Intervention: Drug: Expanded allogenic adipose-derived adult stem cells
11 Completed BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
Condition: Endometriosis
Interventions: Drug: BGS649;   Drug: Placebo
12 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
13 Recruiting Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Conditions: Anxiety Disorder;   Depression;   Fatigue;   Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pain;   Peritoneal Carcinomatosis;   Pseudomyxoma Peritonei;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Gestational Trophoblastic Tumor;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: psychosocial assessment and care;   Behavioral: behavioral intervention;   Other: cognitive intervention;   Other: educational intervention
14 Recruiting Prospective Data Bank Creation to Study Vaginal Conditions
Conditions: Vulvodynia;   Mycoses;   Bacterial Vaginosis;   Preterm Labor
Intervention:
15 Completed
Has Results 		Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
Conditions: Recurrent Cervical Cancer;   Recurrent Vaginal Cancer;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Vaginal Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Therapy-related Toxicity
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Procedure: quality-of-life assessment;   Other: questionnaire administration;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
16 Completed
Has Results 		Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal acidifying gel (RepHresh);   Drug: Metronidazole control
17 Completed Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
Intervention: Drug: Carraguard (PC-515)
18 Completed Vaginal Infection Study
Conditions: Vulvovaginitis;   Vaginitis
Interventions: Drug: clindamycin phosphate/butoconazole nitrate;   Drug: clindamycin phosphate;   Drug: butoconazole nitrate
19 Unknown † A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Drug: Lactofiltrum + Metronidazole;   Drug: Metronidazole
20 Completed Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
Conditions: Bacterial Vaginosis;   Vaginal Discharge
Intervention: Drug: Oral Metronidazole
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years